Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment

被引：0
作者：
Abdou W.A. [1 ]
Aveline C. [1 ]
Bonnet F. [1 ]
机构：
[1] Départment d’Anesthésie-Réanimation Chirurgicale, Hôpital TP
来源：
Acta Neuropathologica | 2001年 / 102卷 / 2期
关键词：
Choline acetyltransferase; Cognitive impairment; Dopamine receptor; Lewy body; Parkinson's disease;
D O I：
10.1007/s004010100372
中图分类号：
学科分类号：
摘要：
Brain tissue from 44 patients with Parkinson's disease (PD) and 36 age-matched controls was examined for choline acetyltransferase (ChAT) activity, and for densities of D1 and D2 dopamine receptors. Brain samples were examined for Alzheimer' disease (AD) type changes and for Lewy bodies (LBs), and for apolipoprotein E genotype. Patients were evaluated for the stage of cognitive impairment using Reisberg's global deterioration scale. ChAT activity in PD was reduced in all brain areas examined, being 51% of the control mean in the hippocampus (P<0.001), 57% in the prefrontal cortex (P< 0.001) and 64% in the temporal cortex (P<0.001). The number of LBs had a significant negative correlation with ChAT activity in both prefrontal (r=-0.33, P<0.05) and temporal cortex (r=-0.32, P<0.05). The reduction in ChAT activity in the prefrontal cortex had a significant negative correlation (r=-0.38, P=0.012) with the extent of cognitive impairment. When the CERAD class 'C' was excluded, cognitive impairment correlated significantly with both prefrontal ChAT activity (r=-0.52, P=0.0051) and the density of D1 dopamine receptors in the caudate nucleus (r=-0.40, P=0.037). The number of D1 and D2 dopamine receptors was reduced in both caudate nucleus and putamen in PD patients without neuroleptics as compared to controls. An increased D2 receptor number was found in the caudate nucleus and putamen in PD patients treated with neuroleptics. The present study showed that cognitive decline in PD is associated with reduced ChAT activity in the prefrontal cortex and the D1 dopamine receptor number in the caudate nucleus, even in the absence of AD-type pathology.
引用
收藏
页码：160 / 166
页数：6
相关论文
共 53 条
  • [11] Fonnum F., A rapid radiochemical method for the determination of choline acetyltransferase, J Neurochem, 24, pp. 407-409, (1975)
  • [12] Gaspar P., Gray F., Dementia in idiopathic Parkinson's disease, Acta Neuropathol (Berl), 64, pp. 43-52, (1984)
  • [13] Gibb W.R.G., Lees A.J., The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease, J Neurol Neurosurg Psychiatry, 51, pp. 745-752, (1988)
  • [14] Gibb W.R.G., Mountjoy C.Q., Mann D.M.A., Lees A.J., A pathological study of the association between Lewy body disease and Alzheimer's disease, J Neurol Neurosurg Psychiatry, 52, pp. 701-708, (1989)
  • [15] Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., Thal L., Pay M.M., Hofstetter R., Klauber M., Rice V., Butters N., Alford M., The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity, Neurology, 40, pp. 1-8, (1990)
  • [16] Hixson J.E., Vernier D.T., Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J Lipid Res, 31, pp. 545-548, (1990)
  • [17] Holthoff V.A., Vieregge P., Kessler J., Pietrzyk U., Herholz K., Bonner J., Wagner R., Wienhard K., Pawlik G., Heiss W.D., Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits, Ann Neurol, 36, pp. 176-182, (1994)
  • [18] Holthoff-Detto V.A., Kessler J., Herholz K., Bonner H., Pietrzyk U., Wurker M., Ghaemi M., Wienhard K., Wagner R., Heiss W.D., Functional effects of striatal dysfunction in Parkinson's disease, Arch Neurol, 54, pp. 145-150, (1997)
  • [19] Kosaka K., Diffuse Lewy body disease in Japan, J Neurol, 237, pp. 197-204, (1990)
  • [20] Lange K.W., Paul G.M., Robbins T.W., Marsden C.D., L-Dopa and frontal cognitive function in Parkinson's disease, Adv Neurol, 60, pp. 475-478, (1993)
123456